Carisma Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Carisma Therapeutics

07/11/2024 15:10

* Carisma Therapeutics Inc  CARM.OQ  reported a quarterly
adjusted
loss of 31 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -53 cents.  The mean expectation of
four analysts for the quarter was for a loss of 26 cents per
share. Wall Street expected results to range from -36 cents
to -10 cents per share.
    * Revenue fell 11.5% to $3.39 million from a year ago;
analysts
expected $5.47 million. 
    * Carisma Therapeutics Inc's reported EPS for the quarter
was a
loss of 31 cents​.
    * The company reported a quarterly loss of $12.7 million.
    * Carisma Therapeutics Inc shares had risen by 13.1% this
quarter and lost 62.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 9.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "buy."

Wall Street's median 12-month price target for Carisma
Therapeutics Inc is $8.00 
This summary was machine generated from LSEG data November 7 at
03:09 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.26          -0.31          Missed
 Jun. 30 2024      -0.30          -0.27          Beat
 Mar. 31 2024      -0.43          -0.46          Missed
 Dec. 31 2023      -0.55          -0.52          Beat